Skip to main content

Follistim AQ FDA Approval History

FDA Approved: Yes (First approved March 24, 2004)
Brand name: Follistim AQ
Generic name: follitropin beta
Dosage form: Injection
Company: Organon USA Inc.
Treatment for: Female Infertility, Hypogonadism, Male, Ovulation Induction

Follistim AQ (follitropin beta) is human follicle-stimulating hormone prescribed for women undergoing assisted reproductive treatments (ART) such as in vitro fertilization (IVF), and for the induction of ovulation to achieve pregnancy, and for men with hypogonadism.

Development timeline for Follistim AQ

Mar 24, 2004Approval Follistim AQ Organon USA Inc. - Treatment for Infertility

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.